Glucocorticoid-prescribing trends in congenital adrenal hyperplasia, 2017 to 2023
Objective: This study investigates the utilisation of modern glucocorticoid medications (Acecort®, Alkindi®, Efmody®, and Plenadren®) for congenital adrenal hyperplasia due to 21-hydroxylase deficiency, examining prescribing patterns, barriers to adoption, and geographical and temporal trends. Metho...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Bioscientifica
2026-03-01
|
| シリーズ: | Endocrine Connections |
| 主題: | |
| オンライン・アクセス: | https://ec.bioscientifica.com/view/journals/ec/15/3/EC-25-0565.xml |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
